INE044A01036
INE044A01036
SUN PHARMACEUTICAL IND L
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 582.201.100.000 | 520.412.500.000 | 11.9% |
| Cost of Revenue | 131.731.400.000 | 121.975.100.000 | 8.0% |
| Gross Profit | 450.469.700.000 | 398.437.400.000 | 13.1% |
| 314.521.500.000 | 272.625.400.000 | 15.4% | |
| Operating Income | 135.948.200.000 | 125.812.000.000 | 8.1% |
| Pretax Income | 151.188.800.000 | 137.521.300.000 | 9.9% |
| Net Income Common Stockholders | 114.794.200.000 | 109.290.400.000 | 5.0% |
| -- | -- | -- | |
| -- | -- | -- |